NYSE - Delayed Quote USD

agilon health, inc. (AGL)

5.50 +0.29 (+5.57%)
At close: May 14 at 4:00 PM EDT
5.65 +0.15 (+2.73%)
Pre-Market: 8:47 AM EDT
Loading Chart for AGL
DELL
  • Previous Close 5.21
  • Open 5.31
  • Bid --
  • Ask 5.54 x 1000
  • Day's Range 5.30 - 5.62
  • 52 Week Range 4.41 - 23.48
  • Volume 6,221,191
  • Avg. Volume 4,701,118
  • Market Cap (intraday) 2.262B
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) --
  • EPS (TTM) -0.49
  • Earnings Date Aug 1, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.34

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

www.agilonhealth.com

1,117

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AGL

Performance Overview: AGL

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AGL
56.18%
S&P 500
10.00%

1-Year Return

AGL
77.23%
S&P 500
27.22%

3-Year Return

AGL
81.13%
S&P 500
27.58%

5-Year Return

AGL
--
S&P 500
25.81%

Compare To: AGL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AGL

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    2.26B

  • Enterprise Value

    1.89B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.46

  • Price/Book (mrq)

    3.28

  • Enterprise Value/Revenue

    0.39

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.85%

  • Return on Assets (ttm)

    -6.62%

  • Return on Equity (ttm)

    -22.82%

  • Revenue (ttm)

    4.87B

  • Net Income Avi to Common (ttm)

    -201.84M

  • Diluted EPS (ttm)

    -0.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    419.06M

  • Total Debt/Equity (mrq)

    6.97%

  • Levered Free Cash Flow (ttm)

    -110.33M

Research Analysis: AGL

Company Insights: AGL

Research Reports: AGL

People Also Watch